Gus Booth-Clibborn  Co-founder and CEO   Gus co-founded Tomo and is in charge of the business development, management and sales. Previously he designed and fundraised for research programmes at the University of Cambridge. For the last three years he has advised investors in the mining, energy and oil and gas sector.

Gus Booth-Clibborn
Co-founder and CEO

Gus co-founded Tomo and is in charge of the business development, management and sales. Previously he designed and fundraised for research programmes at the University of Cambridge. For the last three years he has advised investors in the mining, energy and oil and gas sector.

  Fahad al Saud  Co-founder and Chief Product Officer  Fahad co-founded Tomo and is in charge of the science, coding and product development. He is a neuro-biologist who worked at the National Institute of Medical Research. He also advises a fund on bio-tech, med-tech, and science investments, one of which went to IPO.

Fahad al Saud
Co-founder and Chief Product Officer

Fahad co-founded Tomo and is in charge of the science, coding and product development. He is a neuro-biologist who worked at the National Institute of Medical Research. He also advises a fund on bio-tech, med-tech, and science investments, one of which went to IPO.

   Paolo Valdemarin  CTO   Paolo is a digital industry veteran who has worked with startups for 27 years. He is director of Activate Media, a co-founding partner of startup studio Activate Capital, and co-founder of the State of the Net conference in Italy. He manages development teams in London and Delhi.

Paolo Valdemarin
CTO

Paolo is a digital industry veteran who has worked with startups for 27 years. He is director of Activate Media, a co-founding partner of startup studio Activate Capital, and co-founder of the State of the Net conference in Italy. He manages development teams in London and Delhi.

 
  Duncan Knight   Commercial advisor  Duncan started working with Tomo in February 2017. He is a 2 time co-founder and business advisor. He has worked for more than 25 years in the UK, Australia, Asia, and the US.  Most recently he was  the CEO & CTO of MyCognition, a disruptive HealthTech startup. Duncan advises Tomo on commercial strategy. He is an active member of the TLA Health Working Group.

Duncan Knight
Commercial advisor

Duncan started working with Tomo in February 2017. He is a 2 time co-founder and business advisor. He has worked for more than 25 years in the UK, Australia, Asia, and the US.  Most recently he was  the CEO & CTO of MyCognition, a disruptive HealthTech startup. Duncan advises Tomo on commercial strategy. He is an active member of the TLA Health Working Group.

  Dr Chi-Chi Obuaya  Clinical Director  Chi-Chi is Tomo's Clinical director, joining the team in 2018. He is a consultant psychiatrist working with the NHS in London and in private practice. He is also works with digital psychiatric service Psychiatry UK. He graduated from Royal Free & University College Medical School in 2005, holds an International Health BSc from UCL and an MBA from Imperial.

Dr Chi-Chi Obuaya
Clinical Director

Chi-Chi is Tomo's Clinical director, joining the team in 2018. He is a consultant psychiatrist working with the NHS in London and in private practice. He is also works with digital psychiatric service Psychiatry UK. He graduated from Royal Free & University College Medical School in 2005, holds an International Health BSc from UCL and an MBA from Imperial.